FEATURED NEWS

• Coalition of Public Health Organizations and Supply Chain Partners Launch Educational Initiative to Reduce Opioid Abuse and Misuse

  February 6, 2018

  Today, leading partners across healthcare, public health and the pharmaceutical supply chain joined together to launch Allied Against Opioid Abuse (AAOA), a national education and awareness initiative to help combat the nation’s opioid abuse epidemic.

• TraceLink Will Dismiss Litigation Claims Against Healthcare Distribution Alliance (HDA)

  February 5, 2018

  TraceLink Inc., and the Healthcare Distribution Alliance (HDA) today announced that TraceLink will dismiss litigation claims that it asserted against HDA, which stated that HDA participated in conspiracies to unreasonably restrain trade and to monopolize. TraceLink agreed to the dismissal as they have resolved the misunderstandings that led to their dispute. TraceLink and HDA will work together with other industry players to propose interoperable standards and guidelines for pharmaceutical product master data, with the purpose of enabling compliance with the Drug Supply Chain Security Act of 2013. The two organizations will collaborate and submit standards proposals to GS1 US Healthcare for consideration. To facilitate the development of such proposed standards, HDA will convene a working group in which TraceLink and other vendors and supply chain stakeholders will be invited to participate. The goal of the work group is to provide a forum to develop a proposal for ultimate submission to GS1 US for its consideration. HDA’s Origin and TraceLink’s Life Sciences Cloud will comply with any standard adopted by GS1 US for master data exchange.

• HDA, Supply Chain Partners Support Immediate Action on National Recommendations, Solutions to the Opioid Epidemic

  February 2, 2018

  The Healthcare Distribution Alliance (HDA) and fellow members of the National Conference of Pharmaceutical Organizations (NCPO) have requested a meeting with the Trump Administration to identify and implement specific recommendations included as part of the President’s Commission on Combating Drug Addiction and the Opioid Crisis.

• HDA is One of The Best Places to Work in Virginia for the Eighth Year in a Row

  February 1, 2018

  The Healthcare Distribution Alliance (HDA) was named one of the Best Places to Work in Virginia by Virginia Business magazine and Best Companies Group.

• HDA President and CEO John M. Gray Outlines 2018 Alliance Priorities in Chain Drug Review

  January 8, 2018

  Efforts to mitigate the prescription drug abuse epidemic and activities surrounding DSCSA implementation once again top the list of priorities HDA will be addressing in the year ahead, according to HDA President and CEO John M. Gray. Mr. Gray provided his perspective, along with other healthcare supply chain leaders, as part of Chain Drug Review’s annual “Pharmacy Outlook” feature, published in the January 1 issue.